Pharma Focus Europe


The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.

Tradeup Acquisition Corp. And Estrella Biopharma, Inc. Announce the Successful Completion of Their Business Combination

Saturday, September 30, 2023

Estrella Immunopharma Inc formerly known as TradeUP Acquisition Corp NASDAQ UPTD UPTDW UPTDU has successfully completed its merger with Estrella Biopharma Inc a preclinicalstage biopharmaceutical company specializing in Tcell therapies for blood canc...

Merck KGaA, Darmstadt, Germany and Quris-ai Enhance Their Collaboration

Friday, September 29, 2023

QurisAI an innovative player in the pharmaceutical industry powered by artificial intelligence AI has announced the expansion of its collaboration with Merck KGaA Darmstadt Germany a prominent science and technology company

Immunogenesis Initiates Phase 1a/1b Clinical Trial for IMGS-001 in Patients With Advanced Solid Tumors Who Have Relapsed or Are Refractory

Friday, September 29, 2023

ImmunoGenesis has recently announced the initiation of its Phase ab clinical trial for its lead candidate IMGS at The University of Texas MD Anderson Cancer Center in Houston Texas

Northx Biologics AB Commences Operations at Matfors Facility's New Innovation Hub

Friday, September 29, 2023

NorthX Biologics AB is excited to announce the official opening of its advanced Innovation Hub located at the Matfors facility

Commencement of Immunotherapy Dosing for Leukemia Patients in Phase I/II Trial of ProTcell Therapy SMART101 in ReSET-02

Thursday, September 28, 2023

Smart Immune a clinicalstage biotechnology company focusing on the development of ProTcell a Tcell progenitor therapy platform designed to swiftly rejuvenate the immune system has officially initiated its ReSET Phase III trial for adult acute leukemi...

Pathios Therapeutics Granted Funding by Innovate UK to Assess Novel Immunotherapy Approach in Malignant Brain Cancer Models

Thursday, September 28, 2023

Pathios Therapeutics Limited a biotechnology company dedicated to advancing innovative cancer therapies has been awarded a grant of equivalent to approximately US from Innovate UK

GenSight Biologics Issues Update Regarding Scientific Advice from the European Medicines Agency for LUMEVOQ®

Thursday, September 28, 2023

GenSight Biologics Euronext SIGHT ISIN FR PEAPME eligible has provided an update regarding its discussions with the European Medicines Agency EMA on the design of a new Phase III trial for LUMEVOQ

Novo Nordisk and Evotec Collaborate to Introduce LAB eN², a Translational Drug Discovery Accelerator Targeting Innovation Gaps in Cardiometabolic Diseases

Wednesday, September 27, 2023

Novo Nordisk and Evotec SE have introduced LAB eN a novel program designed to accelerate earlystage research originating from academic institutions with a primary focus on addressing unmet needs in cardiometabolic diseases rare blood disorders and ra...

FDA Approves Chrysalis for Clinical Trials of Chrysalin™ (TP508)

Wednesday, September 27, 2023

Chrysalis BioTherapeutics Inc made an announcement today regarding the approval from the US Food and Drug Administration FDA to commence human clinical trials aimed at treating acute lung failure

Pierre Fabre and Vernalis Laboratories Announce Collaboration in Oncology Drug Research and Development

Tuesday, September 26, 2023

Laboratoires Pierre Fabre and Vernalis RD Ltd a whollyowned subsidiary of HitGen Inc are excited to announce a longterm collaboration aimed at the discovery of preclinical candidates for a variety of oncological targets